The human CGL-1 /cytotoxic serine protease B gene (CSP-B; also known as granzyme B) is transcriptionally activated during cytotoxic T-lymphocyte maturation. Activation can be mimicked in the PEER T-cell leukemia cell line by treatment with 1 2-0-tetradecanoylphorbol-13-acetate (TPA) and N6-2-0-dibutyryladenosine 3,5'-cyclic monophosphate (bt,cAMP). In this report, we show that a consensus AP-1 element and a consensus cAMP response element (CRE) located 5 to the CSP-B transcriptional start site are both required for transcriptional activation of the CSP-B promoter in TPA + bt,cAMP-stimulated PEER cells. A 94-bp fragment containing both elements activates a heterologous promoter in an orientation-independent fashion. Several single nucleotide substitutions in the AP-1 site abolish activity of the 94-bp fragment. Several point muta--LYMPHOCYTE ACTIVATION occurs in vivo after T T-cell receptor (TCR) binding to a foreign antigen presented in the context of a major histocompatibility complex molecule.'-3 A cascade of gene regulatory events then ensues, ultimately leading to the acquisition of an effector cell function, such as cytotoxicity in the case of cytotoxic T lymphocytes (CTLS).~ This maturation occurs over a period of several days. At least 70 proteins are known to increase in quantity during the activation process, and for many of these, protein accumulation is the result of increased gene tran~cription.~ Whereas some genes are turned on within minutes of TCR triggering, others are activated hours or days later. An understanding of the mechanism of regulation of these ''late'' genes should aid in reconstructing the regulatory network that underlies the activation process.
T T-cell receptor (TCR) binding to a foreign antigen presented in the context of a major histocompatibility complex molecule.'-3 A cascade of gene regulatory events then ensues, ultimately leading to the acquisition of an effector cell function, such as cytotoxicity in the case of cytotoxic T lymphocytes (CTLS).~ This maturation occurs over a period of several days. At least 70 proteins are known to increase in quantity during the activation process, and for many of these, protein accumulation is the result of increased gene tran~cription.~ Whereas some genes are turned on within minutes of TCR triggering, others are activated hours or days later. An understanding of the mechanism of regulation of these ''late'' genes should aid in reconstructing the regulatory network that underlies the activation process.
CTLs synthesize "cytolytic" granules during activation.' These granules contain proteoglycans, pore-forming proteins, and a number of serine proteases:-' including the cytotoxic serine protease B gene (CSP-B; also known as CGL-1,9 SECT," HLP," HSE26.1," and granzyme 213 in humans and CTLA-1,I4 CCP-1,l5 and granzyme BI6 in mice). CSP-B is part of a multigene cluster on chromosome 14 that also includes serine proteases expressed in early myeloid cells, mast cells, and natural killer (NK) Expression of CSP-B has been demonstrated in activated (but not resting) T cells in both humans and mice.'2%2@22 We have previously shown that transcriptional upregulation of CSP-B occurs in the PEER T-cell leukemia cell line after exposure to 12-0-tetradecanoylphorbol-1 3-acetate (TPA) and N6-2'-0-dibutyryladenosine 3',5'-cyclic monophosphate (bt,cAMP) ." This activation occurs over a period of 1 to 2 days and involves a change in chromatin conformation and the formation of a DNAse I hypersensitive site upstream from the CSP-B gene. We demonstrated by transient transfection analyses that DNA sequences located between -609 and -80 relative to the transcriptional start site were necessary and sufficient to activate transcription from the CSP-B promoter in activated PEER cells. Furthermore, a CSP-B fragment extending from -1 170 to +3 1 (relative to the transcriptional start site) directs inducible, T-cell-specific expression of a reporter gene in transgenic mice.23 tions in the consensus CRE substantially reduce promoter activity, but one CRE mutation increases activity fourfold. Replacement of the CRE with a second copy of the AP-1 site results in a level of transcriptional activity comparable with that of the wild-type sequence, but replacement of the AP-1 site with a CRE abolishes activity. Neither the AP-1 site nor the CRE can be effectively replaced with an SP-1 site. Deletions between the AP-1 site and the CRE retain full activity only if helical spacing is preserved, suggesting that synergism between these two elements is ei- Analysis of the CSP-B 5' flanking sequences between the transcriptional start site and -609 identified 5 potential regulatory elements that are conserved in sequence and location in the mouse. In this report, we show that 2 of these elements, an AP-1 site and a consensus cAMP response element (CRE), are necessary and sufficient to synergisticially activate transcription from the CSP-B promoter (or a heterologous promoter) in activated PEER y/S T-cells.
MATERIALS AND METHODS
Recombinantplasmids. The Ta2, Vp decamer, AP-1, and CRE sequences in the CSP-B 5' flanking region were scrambled using the linker scanner polymerase chain reaction (PCR) technique (Cheng et al, submitted). Twelve base pairs (bp) encompassing each element were replaced with the sequence GATCCCCCGGGC in the context of a fragment extending from -609 to +3 1 relative to the transcriptional start site. These fragments were subcloned upstream of the bacterial neomycin phosphotransferase gene (neo) in pUC9. The neo gene has been proven to be a suitable reporter using electroporation as means for transient transfection."
A CSP-B fragment extending from -226 to -133 was synthesized by PCR using either the wild-type CSP-B-neo or the CSP-B(AP-1 )-ne0 or CSP-B(CRE)-neo plasmids as templates. The PCR primers had artificial EcoRI sites inserted at the 5' ends, allowing subcloning of the PCR products into the EcoRI site of the -76 CG-neo plasmid." Point mutations in the AP-I site or the CRE were introduced using a similar strategy. In this case, PCR primers 2750 HANSON, GRISOLANO, AND LEY with the appropriate mutations were used to generate fragments extending from -223 to -135, using the wild-type CSP-B promoter as a template. These fragments were digested with EcoRl and subcloned into the -76 CG-neo plasmid as above. All plasmids were sequenced to confirm the presence of the expected mutations.
Plasmids were constructed in which the 43 bp separating the AP-I site and the CRE were replaced with sequences from exon 5 ofthe human growth hormone (hGH)-N gene." An oligomer was synthesized corresponding to sequences from -2 I7 to -140 of wild-type CSP-B in which -200 to -158 was replaced with 43 bp (GATCTT-
CAAGCAGACCTACAGCAAGTTCGACACAAACTCACA)
from exon 5 of hGH. Artificial EcoRl sites were included at both ends ofthe oligomer. The oligomer was annealed to its complementary strand, cut with EcoRI. and subcloned upstream from -76 CG-neo. Plasmids in which the AP-I site was replaced with a CRE or Sp-I element or in which the CRE was replaced with an AP-I or S p l element were constructed in a similar manner. The precise sequences of these oligomers are shown (see Fig 6) .
Plasmids in which the distance between the AP-I and CRE was decreased were constructed with oligomers containing either 5-, IO-, 15-. or 20-bp deletions from the 3' end of the 43-bp hGH sequence (see Fig 7) . These oligomers were also subcloned into the EmRI site upstream of -76 CG-neo. All plasmid sequences were confirmed with the Sequenase kit (US Biochemical, Cleveland, OH) according to the manufacturer's instructions.
7i.ss1iecirltitreandcelltreatment. The PEER cell line was maintained essentially as previously described." In all experiments, PEER cells were activated for 15 hours before transfection by treating them with TPA (Sigma, St Louis. MO) and bt,cAMP (Sigma) at final concentrations of 1.6 X IO-* mol/L and 0.5 mg/mL. respecti vet y. 2o PEER cell transfections were performed as previously described?' Briefly. approximately I X IO' cells in 0.5 mL RPMl I600 (Sigma) were mixed with I5 pg ofsupercoiled test plasmid. 2 pg of supercoiled RSV-neo plasmid, and 200 pg of sonicated salmon sperm DNA in a I X HEBS solution." Samples were electroporated by a single pulse at 330 V and 400 microfarads using the BTX-300 Transfector (BTX Industries, San Diego, CA). After transfection, cells were incubated in fresh media containing TPA + bt2cAMP for 9 hours. Subsequent RNA purification and SI nuclease analysis were performed as described previously.M All expenments were performed at least twice (and many 3 to 5 times) with similar results.
Qitant(fication q/ SI-nitclease protected hands. SI -nuclease protected bands generated from test plasmids were quantified by densitometry and normalized by comparing signals derived from the RSV-neo transfection control plasmid. potential regulatory elements between -609 and the transcriptional start site that are conserved between the two species. To determine whether these sequences play a role in the activation of CSP-B transcription in PEER cells, we "scrambled" 12 bp of DNA in and around each putative cis-acting sequence. All of the "scrambles" are in the context of a CSP-B fragment extending from -609 to +3 1. The nucleotides that were replaced in 4 of the constructions are shown for each element in the lower part of Fig I. The scrambled promoter fragments were cloned upstream from the neo gene as shown and were transfected into PEER cells that had been pretreated for 15 hours with TPA and bt2cAMP. After electroporation, cells were cultured in media containing fresh TPA and bt,cAMP for an additional 9 hours. We have previously shown that the CSP-B gene is transcriptionally activated between 12 and 24 hours of PEER-cell activation.'' Correctly initiated CSP-B-neo mRNA, together with mRNA derived from a cotransfected RSV-neo plasmid, was detected with an S1-nuclease protec- 5' CSP-R seqiiencesfiom -226 to -133 activatea lieterologotis promoter in an orientation-independent manner. Whereas both the AP-I and CRE-containing regions are required for activation of the CSP-B promoter in PEER cells, additional regulatory elements might also be important. We next asked whether CSP-B sequences from -226 to -I33 could activate a heterologous promoter, and whether the AP-I and CRE sequences were again both necessary in this context. A 94-bp fragment containing either wild-type. scrambled AP-I or scrambled CRE sequences was inserted in either orientation upstream from a minimal cathepsin-G (CG) promoter linked to neo (lower part of Fig  2) . As shown in Fig 2, the wild-type CSP-B fragment in either orientation activated the CG promoter when transfected into activated PEER cells (compare lanes 2 and 3 with lane I). In contrast, a CSP-B fragment with a scrambled AP-I site did not activate the promoter (lanes 4 and 5) . The CSP-B fragment with a scrambled CRE activated expression (lanes 6 and 7) to only 4% of the level of the wildtype sequence (determined by densitometric scanning). In previous studies, we had assayed the ability of a CSP-B fragment from -615 to -63 to activate the minimal CG promoter. 20 In that study, activation was orientation-dependent. suggesting that the AP-1 site and the CRE may need to be within a limited distance from the transcriptional start site to activate transcription. In summary. the AP-I and CRE sequences are necessary, and the -226 to -I33 fragment is necessary and sufficient, to activate a heterologous promoter in activated PEER cells.
Point miitations within tlte AP-I site or the CRE alter activation ?/a lieterologoiis promoter. Because the scrambled regions shown in Fig 1 extend beyond the consensus sequences for the individual elements, we next addressed whether individual nucleotides within the consensus AP-I and CRE sequences were required for promoter activation. Three point mutations within the AP-I site at positions -208, -210. and -212, together with a mutation outside the consensus element at position -202, were generated in the context of a CSP-B fragment extending from -223 to -135 (lower part of Fig 3A) . These mutated fragments were subcloned into the CG-neo cassette and transfected into activated PEER cells. As shown in Fig 3A, a mutation expression from the CG promoter (lanes 3 through 5) . Therefore, the activity of the -2 I2 region of the CSP-B promoter maps precisely to the AP-1 site.
A similar experiment was performed with the CRE. Point mutations within the CRE. previously shown to abolish Table 1) .
binding of a 120-kD HeLa-cell nuclear protein with CRE specificity:* were generated in the context of a -223 to -135 CSP-B fragment, which was subcloned into the CGne0 cassette. As shown in Fig 3B, C + A and C + T mutations at position -146 reduced CG-neo expression to the level obtained when the entire CRE is scrambled (lanes 3 and 4, and Table I) . Surprisingly, a C + A mutation at position -149 increases CG-neo expression fourfold compared with the wild-type sequence (lane 5 v lane 2, and Table I) , whereas the C + T mutation at this position was comparable with the -146 mutations. A G + A mutation at -15 I had virtually no effect on the level of CSP-B/CGneo expression (lane 7 ) . Therefore, the activity of the CREcontaining region is different from that of a "classical" CRE.
The AP-1 and CRE elements are necessary and sufficient to activate a heterologous promoter in PEER cells. Alignment of the human and murine CSP-B sequences between -22 I and -134 shows substantial homology in the region extending from the AP-I site to the CRE and conservation of spacing between these two elements (Fig 4) . A total of 60 bp separates the center of the AP-1 site from the center of the CRE in the human, whereas 59 bp separate the two in the mouse. To determine whether sequences located between the AP-l site and the CRE are required for activation, The data shown in this table were derived from densitometric scanning of the autoradiograph shown in Fig 38. The signals detected from CG-neo were normalized for transfection efficiency by comparison with the RSV-neo signal in each lane. This ratio was arbitrarily assigned a value of 1 .OO for the wild-type construct.
For personal use only. on June 9, 2017. by guest www.bloodjournal.org From CSP-B (GRANZYME B) GENE Restricted patterns of regulatory element synergy in promoter activation. Because both the CRE and AP-1 sites are required for high-level expression of a linked promoter, we next addressed whether this synergism could be reproduced by replacing the CRE with an AP-1 site, by replacing the AP-1 site with a CRE, or by replacing either element with an SP-1 site (as a nonspecific consensus element). The oligomers shown in Fig 6 were cloned upstream from CGneo, and the relative levels of expression in activated PEER cells (as determined by densitometry) are indicated. Surprisingly, replacement of the CRE with a second AP-1 site increases the level of CG-neo expression, whereas replacement of the AP-1 site with a second CRE abolishes promoter activity. An SP-1 site is unable to replace the CRE (the level of activity is comparable with that obtained when an AP-1 site alone is present, data not shown) or the AP-1 site. Therefore, the AP-1 site and the CRE appear to play distinct roles in creating a synergistic activation of CSP-B transcription; the AP-1 site can synergize either with itself or a CRE, whereas the CRE synergizes only with the AP-1 element.
Spacing of DNA elements influences synergistic activation by the AP-1 site and the CRE. To further characterize the AP-l/CRE interaction, we examined whether spacing between the DNA elements was critical for synergistic activation. We generated a series of constructions in which the distance between the AP-1 site and the CRE was reduced by 5, 10, 15, or 20 bp. As shown in Fig 7, deletions of 5 and 15 bp reduced expression approximately fourfold and sixfold, respectively, whereas 10-and 20-bp deletions had virtually no effect on the level of expression compared with the wildtype spacing. Therefore, the location of these two elements on the same helical face of DNA appears to be important for the synergistic activation by the AP-1 site and the CRE.
DISCUSSION
The synthesis of cytolytic granules during CTL activation requires the induction of genes encoding granule components during the activation process. We have used TPA + bt,cAMP-stimulated PEER cells as a model to study the late transcriptional activation of the CSP-B gene. In this report, we have shown that activation of the CSP-B promoter in transiently transfected PEER cells treated with TPA and bt,cAMP requires an intact AP-1 site at -2 12 and a CRE at position -152, respectively. These sites activate a heterologous promoter and act independently of the DNA sequences found between them.
Two DNA sequences previously associated with T-lymphocyte-specific genes are found in conserved locations upstream of the human and murine CSP-B promoters. Intracellular signals that appear during T-cell activation have been studied in a number of systems. Treatment with TPA mimics activation via the TCR,30 and treatment with agents that increase intracellular cAMP results in cellular events associated with lymphocyte activation, including induction of NF-KB~' and the onset of DNA synthesis.32 Furthermore, synergy between TPA and agents that increase cAMP levels, including interleukin-1 (IL-l), has been shown to enhance AP-1 activity in T cells.33 Disruption of either the AP-1 site at position -2 12 or the CRE at position -152 eliminated (AP-1) or substantially reduced (CRE) expression from a transfected CSP-B or CG promoter in activated PEER cells. Point mutations in the AP-1 site known to disrupt binding by the fos/jun heterodimeP4 also abolished transcriptional activity, but a point mutation outside the AP-1 site had no effect. This suggests that members of the fos and jun families of transcription factors might be involved in CSP-B activation. Three members of the jun family and four members of the fos family have been identified.35-41 One or more members of each family could conceivably be late-activated in PEER cells and be responsible for mediating the "AP-1" effect. Interestingly, the lym- phoid-specific nuclear factor of activated T cells (NF-AT), which can bind to an AP-I site in the IL-2 gene-enhancer region and presumably activate transcription, has recently been shown to be a complex containing the proteins Fra-I and J u~B .~~.~' In one study, Northern blot analysis showed HANSON, GRISOLANO, AND LEY induction ofjunB mRNA that was maintained for at least 6 to 12 hours after activation, whereas Fra-l mRNA, although induced several-fold after activation, was detectable in resting. primary human T Based on these findings, it is possible that NF-AT may be a factor that acts on the CSP-B promoter. In any case, the identity of the factor(s) that bind the AP-I site in the CSP-B promoter has yet to be determined.
Scrambling ofsequences containing the CRE resulted in a substantial reduction of CSP-B promoter activity. Point mutations that had previously been shown to abolish binding of a HeLa-cell nuclear protein to the CRE2* had opposite effects in transfection experiments. The -146 mutations reduced expression to the level obtained when the CRE is completely scrambled, as did the -149 C -c T mutation. In contrast, the -149 C + A mutation increased expression fourfold relative to the wild-type construct. Interestingly, this particular mutation creates a consensus binding 
I -
hybridized to a CG-neo probe, and analyzed by S1-nuclease protection. S I -nuclease protected bands were quantified by densitometry. Relative activi- We were surprised to find that replacing the CRE with a second AP-I site in the AP-I-hGH-AP-l/CG-neo construct resulted in activation of the CG promoter. This may indicate that the same transcription factor binds both elements. This seems plausible, because Jun homodimers can bind CREs. However, if this were true, then a single AP-I site ought to be sufficient for activation, as has been shown in other systems. 60 Because this is not the case, an alternative explanation may be that assembly of the transcription complex requires two stabilizing factors; perhaps only one of these factors needs to be absolutely specific. The inability of the CRE-hGH-CRE oligomer to activate the CG promoter may be due to incompatibility of two CRE-BPs in the stabilization complex or to a lower affinity of the CRE relative to the AP-I site, which results in subthreshold binding of transcription factors. In any case, further analysis of the mechanisms underlying AP-1 /CRE synergy in activation of the CSP-B promoter awaits the identification and characterization of the transcription factors that bind these motifs in vivo.
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NOTE ADDED IN PROOF
Haddad et aI6' recently reported that the -148 to +60 region ofthe human granzyme B gene is important for transcriptional activation in PHA-activated T lymphocytes and CD3-activated Jurkat T cells.
